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Abstract
Purpose The Covid-19 pandemic has disrupted health care systems all over the world. Elective surgical procedures have 
been postponed and/or cancelled. Consensus is, therefore, required related to the factors that need to be in place before elec-
tive surgery, including hip and knee replacement surgery, which is restarted. Entirely new pathways and protocols need to 
be worked out.
Methods A panel of experts from the European Hip Society and European Knee Association have agreed to a consensus 
statement on how to reintroduce elective arthroplasty surgery safely. The recommendations are based on the best available 
evidence and have been validated in a separate survey.
Results The guidelines are based on five themes: modification and/or reorganisation of hospital wards. Restrictions on 
orthopaedic wards and in operation suite(s). Additional disinfection of the environment. The role of ultra-clean operation 
theatres. Personal protective equipment enhancement.
Conclusion Apart from the following national and local guidance, protocols need to be put in place in the patient pathway 
for primary arthroplasty to allow for a safe return.
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Introduction
In recent months, the SARS-CoV-2 pandemic has evolved 
rapidly in Europe, disrupting the personal, social, eco-
nomic and professional lives of health professionals on 
a large scale. The overall goal of most governments in 
Europe has been to flatten the curve of infected SARS-
CoV-2 patients and prevent a collapse of national health 
systems. The April 2020 SARS-CoV-2 survey completed 
by EHS and EKA members in Europe has confirmed the 
impact of SARS-CoV-2. This pandemic has resulted in a 
tremendous reduction in primary hip and knee arthroplas-
ties performed. Consensus is required about the factors 
that need to be in place before restarting such procedures.
Delaying hip and knee arthroplasty in patients with 
severe osteoarthritis (OA) may adversely affect their final 
outcome. It lead to increased opioid use. It is associated 
with lower clinical results and increased readmission rates 
after the index procedure. Moreover, when access to hip 
and knee arthroplasty is limited, as it is now in the wake 
of the SARS-CoV-2 virus control measures, the direct and 
indirect costs for health care and social systems are enor-
mous. Many patients suffering from OA have to prolong 
their absence from work, request temporary unemploy-
ment benefits, and/or burden the public welfare system.
A new phase is now starting in most European coun-
tries, where restarting elective hip and knee arthroplasty 
surgery is being planned. The existing guidelines are 
not robust enough and therefore, improvement is much 
needed. The aim of this report is to describe the optimal 
trajectory for restarting elective hip and knee arthroplasty 
surgery. As a result, the European Hip Society (EHS) and 
the European Knee Association (EKA) worked with a 
panel of experts and have produced a thorough consensus 
report on how safe reintroduction of elective arthroplasty 
surgery can be achieved. The recommendations are based 
on the most recent available evidence and have been vali-
dated in a survey by world-wide arthroplasty surgeons.
Method
A panel of experts were tasked with reviewing the evidence 
available for managing primary elective hip and knee arthro-
plasty following the SARS-CoV-2 pandemic were asked:
Five basic questions
1. When should elective hip and knee arthroplasty be 
resumed?
2. Are new triage/patient selection criteria needed for hip 
and knee arthroplasty patients once elective surgery is 
resumes?
3. What are the priority indications for elective adult hip 
and knee reconstruction?
4. What is the role of outpatient hip and knee arthroplasty/
enhanced recovery protocols in light of the SARS-
CoV-2 pandemic?
5. What is the impact of delaying hip and knee arthroplasty 
for the patients themselves and for society?
Preoperative phase
1. What is the appropriate preoperative clinical and labora-
tory screening and timeline for patients?
2. Is preoperative tracking of patients, staff and relatives 
necessary?
3. Should spinal anaesthesia be routine?
• Should only patients who also consent to regional/
spinal anaesthesia be selected as candidates?
• If spinal anaesthesia does not occur, should the oper-
ation be cancelled?
4. If the SARS-CoV-2 tests are positive, how long should 
the hip or knee arthroplasty surgery be postponed?
5. What kind of back-up plan is needed to guarantee quality 
care and patient safety in this pandemic situation?
Perioperative phase
1. Is there a need for:
• Modification or reorganization of hospital wards 
(patient density, bed density, medical and nursing 
stuff density, etc.)?
• Separation of elective and trauma orthopaedic sur-
gery (with regard to the general orthopaedic depart-
ments)?
2. Should relatives/visitors or other supportive personnel 
be allowed onto the orthopaedic wards and operating 
suite?
3. Is there a need for extra disinfecting environmental pro-
cedures in between operations?
4. What roles do ultra-clean operating theatres, orthopaedic 
exhaust suits and ultraviolet light systems play in both 
the wards/beds and the theatre?
5. What are the guidelines for personal protective equip-
ment (PPE), in terms of availability and instructions 
regarding its use and what to wear in relation to the 
patient’s position in the perioperative chain?
2732 Knee Surgery, Sports Traumatology, Arthroscopy (2020) 28:2730–2746
1 3
Post‑operative phase
1. Since the impact on mind and body during joint arthro-
plasty is significant, do the patients may have lower 
immunity and be more vulnerable to SARS-CoV-2 
infection?
2. Should a shelter-in-place post-operative period, home 
care, community nurses or informal care be organised?
3. Should face-to-face contact for the orthopaedic follow-
up and physical therapy guidance be avoided?
• Consider telemedicine
• Consider a new approach in wound closure technique 
in the setting of the SARS-CoV-2 pandemic
4. What is the advice for patients who develop SARS-
CoV-2 symptoms?
5. Are special adjustments needed for post-op SARS-
CoV-2 prophylaxis?
The panel then agreed a statement that answered 
each question, along with reporting the rationale for the 
recommendation.
Results
Five basic questions
1. When should elective hip and knee arthroplasty be 
resumed?
Statement Elective hip and knee arthroplasty can be resumed 
when appropriate prerequisites concerning facilities, work-
force, testing, supplies are met, and approval of local health 
authorities is obtained. Facilities in areas with low, or rel-
atively low and stable incidence of SARS-CoV-2, can be 
allowed to provide care for patients needing non-emergency, 
non-SARS-CoV-2 healthcare.
Rationale The US Centers for Disease Control advise that 
the following gating criteria to be met before reopening 
facilities to provide non-emergency health care [43]:
• Downward trajectory of cases with influenza-like and 
COVID symptoms within the last 14 days.
• Downward trajectory of documented cases and positive 
tests as a percentage of total tests within 14 days
• Hospitals have treated all COVID cases without crisis 
care
• Robust testing programme in place for at-risk health care 
workers, including emerging antibody testing
Depending on the country and the locations involved, 
some hospitals may be overburdened, while non-COVID 
care facilities may be inactive. The US Centers for Medicare 
& Medicaid Services (CMS), in their ‘Recommendations for 
Re-opening Facilities to Provide Non-emergent Non-SARS-
CoV-2 Health Care’ [6], advise careful consideration of the 
availability of adequate facilities, testing and supplies, plus 
an adequate workforce, across all the phases of care (e.g. 
clinicians, nurses, anaesthesia, pharmacy, imaging, pathol-
ogy support and post-acute care).
The International Consensus Group (ICM) and the 
AAHKS Research Committee advise that the following 
prerequisites be met before the resumption of elective pro-
cedures [29]:
• Timing of resumption: There must be a sustained reduc-
tion in the rate of new SARS-CoV-2 cases in the relevant 
geographic area for at least 14 days before the resumption 
of elective surgical procedures [6, 29, 32, 43]
• Any resumption should be authorised by the appropriate 
municipal, county and state health authorities
• Facilities in the state are safely able to treat all patients 
requiring hospitalisation without resorting to crisis stand-
ards of care
• The facility needs to have an appropriate number of ICU 
and non-ICU beds, PPE items, ventilators, medications, 
anaesthetics and medical surgical supplies to cope with 
a second wave of pandemic
• Appropriate decontamination of the hospital and neces-
sary equipment has occurred
• The facility needs to have an adequate number of trained 
and educated staff available to handle the planned surgi-
cal procedures, patient population and facility resources. 
Given the known evidence supporting health care worker 
fatigue and the impact of stress, the facilities should be 
able to perform planned procedures to organise two dif-
ferent pathways inside the structure for SARS-CoV-2 
and non-COVID patients without compromising patient 
safety or staff well-being
• Ideally, all the staff who will be involved in patient care 
have been tested for SARS-CoV-2 (RT-PCR) on a regular 
basis and/or undergone serum antibody testing for the 
virus
• The facility should be able and to have two different, sep-
arated surgical blocks for the two categories of patients
ESSKA Guidelines also focus on the SARS-CoV-2 expo-
sure status of the patient described by Fineberg and recom-
mend elective surgery only in the first three of the following 
six categories [12, 25]:
• Exposure-to-infection status unknown. Should get a 
COVID RT-PCR test 48–72 h before surgery (plus other 
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means according to your institutional rules and regula-
tions)
• Exposed but asymptomatic. Should get a COVID RT-
PCR test, immune/serology test (if allowed and available) 
and eventually a lung CT scan before surgery
• Recovered from infection and possibly adequately 
immune. Should get an immune/serology test (if allowed 
and available) before surgery
• Presumed to be infected (persons with signs and symp-
toms consistent with infection who initially tested nega-
tive). Should get a repeated COVID RT-PCR test, an 
immune/serology test (if allowed and available) and 
eventually a lung CT scan before considering any sur-
geries
• Infected (COVID-kit test—eventually a lung CT scan). 
Delay any elective surgery for 6 weeks and then should 
get an immune/serology test (if allowed and available) 
before surgery
• Infected with co-morbidity (COVID-kit test—eventually 
a lung CT scan). Delay any elective surgery until full 
recovery (for at least 2 months) and then should get an 
immune/serology test (if allowed and available)
2. Are new triage/patient selection criteria needed for hip 
and knee arthroplasty patients once elective surgery is 
resumes?
 Statement Increased demand for hip and knee arthro-
plasty, coupled with limited hospital resources, will 
force surgeons to select which patients should receive 
hip and knee arthroplasties sooner than others. This will 
entail employing objective, transparent criteria in prior-
itising patient selection to identify the patients most in 
need who also have lower risk factors for disease trans-
mission and post-operative complications.
 Rationale An increased demand for hip and knee 
arthroplasty care is foreseen once elective procedures 
are resumed in Europe, where public health systems are 
the major health care payers. Conversely, in countries 
where health insurance is linked to employment and 
private insurance companies are the main payers (e.g. 
the USA), demand may decline due to unemployment/
underemployment or people’s need to continue working 
for economic reasons despite their symptoms. Several 
guidelines are available for prioritising patients undergo-
ing elective surgery.
The MeNTS Score (Medically Needed Time Sensitive 
Procedures Score) [32] is a scoring system that takes the 
following into account:
• Procedural factors (overall procedure time, blood loss, 
need for ICU, intubation probability)
• Disease factors (viability of non-operative treatment, 
increased surgical difficulty and risk with delaying the 
procedure)
• Patient factors (age, cardiopulmonary disease, diabe-
tes, influenza-like symptoms and exposure to COVID-
19-positive person)
The score can range from 21 to 105, with higher scores 
being associated with poorer perioperative patient outcomes, 
increased risk of SARS-CoV-2 transmission to the health 
care team, and/or increased hospital resource use. Although 
there is no threshold for safe elective surgery, the hospitals 
can adjust their thresholds depending on resources.
The International Consensus Group (ICM) and the 
AAHKS Research Committee [32] recommend delaying 
elective surgery for patients over 75 years old with cardio-
pulmonary co-morbidities, patients with morbid obesity, 
transplant patients undergoing immunosuppression and 
patients with active cancer.
ESSKA guidelines [10] advise giving priority treatment 
to younger patients (< 60), requiring fewer than 3 days of 
hospitalisation and delaying elective surgery for patients 
with co-morbidities.
3. What are the priority indications for elective adult hip 
and knee reconstruction?
 Statement There is universal agreement regarding the 
indications for urgent hip and knee arthroplasty pro-
cedures, such as femoral neck fractures, periprosthetic 
fractures, dislocations and acute infection, even in the 
setting of the SARS-CoV-2 pandemic. However, priority 
indications for non-emergency procedures in primary 
and revision hip and knee arthroplasty are lacking and 
should be clarified.
EHS and EKA priority indications for elective adult hip 
and knee arthroplasty:
• Acute fractures requiring hip and knee arthroplasty 
(periprosthetic fractures, THA/hemi-arthroplasty for 
femoral neck fractures)
• First-stage explantations for acute PJI (periprosthetic 
joint infection)
• Amputation in cases of failed arthroplasty
• One-stage revision for acute PJI
• Revision surgery required for massively failed arthro-
plasty: imminent fracture, massive osteolysis at risk of 
implant migration, implant breakage, pending fractures 
because of osteolysis or instability, severe adverse reac-
tion to metal debris (ALTR or ARMD)
• Osteonecrosis with joint collapse, avascular head necro-
sis (AVN)
• Patient with severe articular deformity and/or instability
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• First-stage explantations for chronic PJI
• One-stage revision for chronic PJI
• Patient with severe arthritic condition and/or pain forced 
to stop working (rapid progressive osteoarthritis)
• Total joint arthroplasty reconstruction after bone sarcoma 
resection
• Second stage for treatment of an infected joint arthro-
plasty
• Conversion from osteosynthesis to total joint arthroplasty
• Operations required because prolonged delay could 
prevent the appropriate surgery from being performed 
adequately
• Patient with severe functional impairment compromising 
autonomy and ability to walk
• Patient with inability to walk and requiring important 
technical aid (wheelchair, home care, human assistance)
• Patient with chronic severe arthritic pain requiring opioid 
use
Rationale Several guidelines outline the urgent indications 
for hip and knee arthroplasty surgery. The American College 
of Surgeons’ ‘COVID 19: Elective Case Triage Guidelines 
for Surgical Care Guidelines on Surgery’ describe the fol-
lowing conditions as priority indications for hip and knee 
arthroplasty surgery: hip dislocation, knee dislocation, 
periprosthetic fracture, acute pain exacerbation in prior 
joint arthroplasty, inability to bear weight on the extrem-
ity, wound drainage, fever and concern for periprosthetic 
infection.
The International Consensus Group and the AAHKS 
Research Committee recommend priority surgery for 
impending fracture and exposed implants, in addition to the 
conditions outlined above.
It would be helpful to have guidelines covering the prior-
ity indications for elective surgery for primary hip and knee 
arthroplasty, with a stratification of patient symptoms, dis-
ability, disease severity and soft/tissue bone compromise. 
Examples might include femoral head collapse in avascular 
necrosis, severe disability, and painful bone marrow oedema. 
The same should be done for revision indications, such as 
bone loss, impending fracture, extensor mechanism disrup-
tion, patella dislocation, severe osteolysis, massively failed 
implants, and second stage implantation of infections.
4. What is the role of outpatient hip and knee arthroplasty/
enhanced recovery protocols in light of the SARS-
CoV-2 pandemic?
Statement It is universally accepted that shorter hospital 
stays and treatment in a SARS-CoV-2-free environment 
decrease the risk of SARS-CoV-2 infection in patients 
undergoing elective surgery. Performing hip and knee 
arthroplasty with enhanced recovery protocols that decrease 
the length of stay in a facility or can be used in ambulatory 
care centres to allow for day surgery might be beneficial 
for reducing the risk of viral transmission. Transitioning to 
enhanced recovery systems requires full support, adoption 
of all the subspecialties involved and the possible approval 
of health care payers, which may not be possible in the pan-
demic setting.
Rationale Enhanced recovery protocols for hip and knee 
arthroplasty have been shown to decrease length of stay 
without increasing complications in appropriate patients [40, 
44]. These protocols require a graduated, multi-specialty 
approach, with refinements being performed according to 
each centre’s needs [42]. Transitioning to enhanced recov-
ery protocols might be difficult in the setting of the SARS-
CoV-2 pandemic, but it must be an intermediate-term goal, 
involving the health care payers if necessary.
Although the quality of evidence is not very high, outpa-
tient (day case) hip and knee arthroplasties have been shown 
to be safe and effective in select patients [31]. Medicare has 
allowed total knee arthroplasties (since 2018) and hip arthro-
plasties (since 2020) in ambulatory care centres in the USA. 
With the hospitals burdened with SARS-CoV-2 care, these 
ambulatory centres can provide the services needed for hip 
and knee arthroplasty without draining hospital resources. 
Protocols must be developed for performing hip and knee 
arthroplasties safely in such centres [24].
The American College of Surgeons’ advice is to adhere 
to standardised care protocols as much as possible (e.g. 
enhanced recovery protocols) for increased reliability in 
light of potential variability in available personnel, since 
standardized protocols optimise patient safety, minimise 
hospital stays and increase efficiency. They are associated 
with decreased complication rates.
5. What is the impact of delaying hip and knee arthroplasty 
for the patients themselves and for society?
Statement Delaying elective hip and knee arthroplasty has 
negative consequences on the quality of life of patients and 
negatively impacts society as a whole. The benefits of hip 
and knee arthroplasty should be carefully weighed against 
the risks of viral transmission and infection, complications 
and mortality in the mostly elderly population requiring joint 
arthroplasty.
Rationale In the face of the SARS-CoV-2 pandemic, elec-
tive hip and knee arthroplasty procedures may have been 
delayed or cancelled by the health authorities or by patients 
fearing viral spread. The consequences of delayed hip and 
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knee arthroplasty for patients have not been studied exten-
sively. A survey of 360 patients with cancelled arthroplasties 
by Brown et al. [5] showed that daily symptoms of arthritis 
were unchanged or exacerbated in most patients and limita-
tions at home were significant for 15–20% of them. This 
study also found that not knowing when the procedure would 
be rescheduled caused moderate to severe anxiety in 60% of 
patients. Similar findings were documented by D’Apolito 
[9]. Becoming infected with SARS-CoV-2, and spreading 
the infection to others, were also high causes of anxiety. 
Regardless of the SARS-CoV-2 pandemic, delaying hip and 
knee arthroplasty is also associated with increased disabil-
ity, deterioration of function, less benefit from surgery and 
worse functional recovery in the early post-operative period 
[14, 34].
The SARS-CoV-2 pandemic has placed an enormous eco-
nomic burden on the global economy. The effect of any eco-
nomic downturn is usually a decrease in elective procedures 
[13]. This decrease is exacerbated in the present situation by 
fears of viral spread, limitations of travel and stay-at-home 
precautions enforced at different levels in various countries. 
The direct effect of delaying hip and knee arthroplasty in the 
face of the SARS-CoV-2 pandemic is not known. Previous 
work has shown that both hip and knee arthroplasty have 
been shown to have societal benefits in terms of increased 
productivity and earnings and decreased disability pay and 
missed workdays [18, 35]. A Markov analysis of total hip 
arthroplasty in Germany by Mujica-Mota et al. [26] showed 
that the expected benefit of having timely THR is substan-
tial for patients in terms of health related to quality of life, 
ranging from the equivalent of an additional 3.15 years of 
life in full health for a 65-year-old male person to 3.93 extra 
years for a 55-year-old woman. These benefits may be lost 
if elective procedures are delayed for longer periods of time.
Preoperative phase
1. What is the appropriate preoperative clinical and labora-
tory screening and timeline for patients?
Statement All patients undergoing surgery should have their 
temperature and oxygen saturation measured [2]. A thor-
ough medical history should be acquired and patients asked 
about any symptoms they may have, such as cough, fever, 
loss of smell or taste, headache or gastrointestinal disorders. 
Additionally, they should be questioned about recent travels 
and their occupation to stratify them into possible high-risk 
groups. Regarding the laboratory testing, it would be ideal 
for all patients to undergo RT-PCR testing for SARS-CoV-2 
before the operation [30]. However, local guidelines and 
the efficacy of tests must also be taken into consideration. 
If there is a paucity of available tests, then only high-risk 
patients should be tested. There is no indication for addi-
tional chest CT scans in the preoperative screening. Time 
allowing, all surgical patients should apply social distancing 
principles for two full weeks prior to testing and the surgical 
procedure and self-quarantine in their home for the period 
between test acquisition and day of surgery.
Rationale It is known that patients who remain asympto-
matic (30% of exposed cases) or mildly symptomatic (56% 
of exposed cases) can transmit the infection. Taking these 
facts into consideration, patients who are scheduled for sur-
gery should always be assumed to be potential carriers of 
the virus throughout the duration of their hospital or clinical 
stay, even if they pass the pre-assessment triage, including 
normal temperature, no history of exposure or travel and no 
respiratory symptoms [2]. Not being aggressive with testing 
while carrying out surgical services could have catastrophic 
consequences.
There are two categories of SARS-CoV-2 tests: tests that 
detect the virus itself (viral ribonucleic acid [RNA]) and 
tests that detect the host’s response to the virus (serological 
antibodies) [30]:
• Nucleic acid amplification tests for viral RNA: Detec-
tion of the virus is achieved by identifying the viral 
RNA through nucleic acid amplification, usually using a 
polymerase chain reaction (PCR). The most commonly 
tested sample types are swabs taken from the nasophar-
ynx (more sensitive) and/or oropharynx. Swabs are then 
placed into a liquid to release viral RNA into the solution 
and subsequently amplified using reverse transcription 
PCR. These tests are the gold standard for acute illness. 
Accuracy of the test is affected by the quality of the 
sample, and RNA may degrade over time. Since SARS-
CoV-2 can infect anyone and result in transmission prior 
to the onset of symptoms, or possibly even without indi-
viduals ever developing symptoms, aggressive testing/
screening of asymptomatic patients has been considered.
• Antibody detection via serology: The other broad cat-
egory of tests include those detecting IgM, IgA, IgG or 
total antibodies. Clinicians should note that SARS-CoV-2 
is not typically present in blood. An infection causes 
white blood cells to make antibody proteins that help 
the immune system identify the virus and stop it or mark 
infected cells for destruction. Development of an anti-
body response to infection is host-dependent and takes 
time. In the case of SARS-CoV-2, studies suggest that 
most of the patients seroconvert in 7–11 days after expo-
sure to the virus, although some patients may develop 
antibodies sooner. Therefore, antibody testing is not use-
ful in the setting of an acute illness. It is still unknown 
whether individuals infected with SARS-CoV-2 who 
subsequently recover will be protected, either fully or 
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partially, from future infection with SARS-CoV-2 or for 
how long the protective immunity may last.
The Dutch Medical Federation states in their guidelines 
that patients reporting no symptoms of SARS-CoV-2 after 
a thorough history taking may be either without infection, 
asymptomatic or pre-symptomatic. An asymptomatic patient 
carries the SARS-CoV2 virus but never experiences notice-
able symptoms. A pre-symptomatic patient experiences no 
symptoms of SARS-CoV-2 at the time of evaluation but will 
go on to subsequently develop SARS-CoV-2 symptoms in 
the future. When a patient reports no symptoms of SARS-
CoV-2 during preoperative screening, it is therefore impos-
sible to make a clinically relevant distinction between the 
three categories of no SARS-CoV-2 infection, asymptomatic 
SARS-CoV-2 infection, or pre-symptomatic SARS-CoV-2 
infection. This means that patients who are initially asymp-
tomatic, pre-symptomatic or mildly symptomatic can sub-
sequently develop moderate to severe SARS-CoV-2 disease, 
placing them at significant risk for adverse post-operative 
outcomes, that is, ICU admittance or increased mortality 
[3, 22].
Concerning the chest CT, the Dutch Medical Federa-
tion’s recent advice is outlined as follows. The commit-
tee’s primary aim for the work-up for SARS-CoV-2 is to 
identify SARS-CoV-2-positive cases (high sensitivity) to 
limit transmission by rescheduling surgery, if possible, or 
allowing necessary precautions to be taken. Therefore, the 
committee initially advised that all adult patients requir-
ing a surgical procedure under general anaesthesia undergo 
preoperative screening for SARS-CoV-2 infection through 
the use of SARS-CoV-2 PCR of a deep nasopharyngeal 
swab, in conjunction with a low-dose chest CT (without 
i.v. contrast). Preliminary data show 1–2% SARS-CoV-2 
infection among preoperative patients reporting no symp-
toms of SARS-CoV-2. This may seem a low percentage. 
However operative health care workers undergo repeated 
exposure during aerosol-generating swab. However, the 
added value of chest CT is low. Therefore, the committee 
is of the opinion that there is no longer an indication pro-
cedures and other risk-bearing procedures. The cumulative 
exposure to SARS-CoV-2-positive patients for these health 
care workers through aerosolisation is therefore assumed to 
be high. In addition, transmission to other patients remains 
an unknown risk factor. The committee’s opinion is that this 
percentage justifies preoperative testing through the use of 
SARS-CoV-2 PCR of a deep nasopharyngeal for the use of 
chest CT in preoperative testing of asymptomatic patients.
ESSKA guidelines focus on the SARS-CoV-2 exposure 
statuses of patients described by Fineberg. Risk factors 
(e.g. age > 60 years, obesity, high blood pressure, cardio-
vascular disease and diabetes) are disqualifying conditions 
in this early phase (and should always be discussed with 
the anaesthetist). The ESSKA is recommending a preop-
erative questionnaire; detailed discussions with the patient 
about their situation (e.g. by tele- or videoconference); and 
a SARS-CoV-2 RT-PCR test and/or immune/serology test 
48 to 72 h before the operation.
OrthoEvidence recommends the screening and detec-
tion of SARS-CoV-2 patients for the safe introduction of 
elective surgery and preservation of vital supplies.
The International Consensus Group (ICM) and the 
AAHKS Research Committee recommend that testing of 
patients should be mandatory in high-prevalence areas, 
given the risk of disease transmission by asymptomatic 
patients. Routine testing is not feasible in all locations 
because of limitations in testing capacity, though, and 
therefore local guidelines should be followed in those 
areas.
2. Is preoperative tracking of patients, staff and relatives 
necessary?
 Statement All patients and staff will need to be screened 
for potential symptoms of SARS-CoV-2 prior to enter-
ing a hospital facility. In particular, staff must be rou-
tinely screened for potential symptoms. Isolation prior 
to surgery can be guided. All patients, staff and relatives, 
especially those with patient contact, need to be inves-
tigated for previous symptoms, travels abroad and pos-
sible contacts with populations at high-risk for SARS-
CoV-2.
Rationale Park et al. [28] describe an outbreak at a call cen-
tre in South Korea. Out of 1143 people, 97 were COVID-19 
positive, 94 of whom were from the building. The propor-
tion of pre-symptomatic persons was 4%, and none of the 
housemates of these persons became infected (versus 16.5% 
of the housemates of symptomatic persons). The authors 
concluded that easily accessible testing of symptomatic per-
sons, contact tracing and taking isolation measures were the 
preferred methods of control. Effective screening of patients 
and caregivers is necessary to prevent post-operative devel-
opment of severe COVID-19 disease in a vulnerable patient 
population.
The ESSKA guidelines and the International Consensus 
Group (ICM) and AAHKS Research Committee recommen-
dations have a preoperative questionnaire included which 
can be used for COVID-19 screening.
3. Should spinal anaesthesia be routine?
 Statement Spinal anaesthesia can be considered safer 
for every negatively screened patient (with or without 
a SARS-CoV-2 test) than general anaesthesia, since the 
latter requires airway manipulation and endotracheal 
intubation, procedures that can more easily transmit 
SARS-CoV-2 [23].
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• Should only patients who also consent to regional/spi-
nal anaesthesia be selected as candidates?
  Statement It cannot be made mandatory that patients 
consent to regional/spinal anaesthesia. Nevertheless, 
the benefits of regional anaesthesia should be thor-
oughly explained to the patients, and whenever possi-
ble, this should be strongly considered as the preferred 
means of anaesthesia.
Rationale General anaesthesia, which requires airway 
manipulation, endotracheal intubation and positive ventila-
tion, is more predisposed to transmitting SARS-CoV-2 to 
the anaesthetic and surgical teams. Transmission can occur 
from asymptomatic patients.
• If spinal anaesthesia does not occur, should the opera-
tion be cancelled?
Statement If general anaesthesia cannot be avoided, every 
precaution should be taken to avoid contamination. If a 
SARS-CoV-2-negative environment has been achieved 
that is as secure as possible, then general anaesthesia with 
informed consent can be considered.
Rationale Cancellation of surgery is a constant, agonis-
ing dilemma for nearly all health care services in terms 
of the wasting of resources and inconvenience caused to 
both patients and families. Deciding to cancel a hip or knee 
arthroplasty surgery means rescheduling long-anticipated, 
life-changing surgery for the patient. Patients undergoing 
elective surgery should be educated as to the spinal/general 
anaesthesia protocols that are in place for minimizing SARS-
CoV-2 transmission to themselves, their family members, 
other patients and hospital personnel.
OrthoEvidence clearly states that we need further 
research on identifying the ideal screening process for 
asymptomatic surgical patients, so in general anaesthe-
sia cases, we should consider taking additional meas-
ures beyond those required for an operation under spinal 
anaesthesia.
The American Society of Anesthesiologists’ guidelines 
suggest that the anaesthetic professional should consider 
measures that limit the potential for aerosolisation of drop-
let particles. The following should be considered for all 
patients:
• Surface and equipment cleaning during and between 
cases (e.g. have a rigid protocol for anaesthetic machine 
interface, bag, monitors, surfaces, door handles, etc.; 
avoid unnecessary clutter)
• Wear gloves (change regularly and when soiled)
• Regular hand washing and avoid contamination of mucus 
membranes (gloved hands may remind you to not touch 
your mucus membranes)
• Avoid high-flow devices, especially if not wearing PPE
• Consider Video Laryngoscopy for intubation to distance 
yourself from the airway and/or wear mask and eye pro-
tection, sheath all reusable equipment where possible and 
ensure appropriate disinfection procedures
The International Consensus Group (ICM) and the 
AAHKS Research Committee recommend the use of 
regional anaesthesia whenever possible and say it should 
be strongly considered for patients undergoing elective sur-
gery during the pandemic. For patients undergoing elective 
surgery, education is mandatory on the protocols that are in 
place to minimise SARS-CoV-2 transmission to themselves, 
their family members, other patients and hospital personnel. 
An overview of the protocols implemented by the hospital 
to reduce the risk of transmission of the infection should be 
included.
The advice of the American College of Surgeons is to 
consider the guidelines in place, for personnel to be present 
during intubation, and to consider including a waiting period 
before beginning the operation to account for air circulation 
cycling time.
4. If the SARS-CoV-2 tests are positive, how long should 
the hip or knee arthroplasty surgery be postponed?
Statement It is reasonable to assume that patients who test 
positive for SARS-CoV-2 should not be operated on and 
should be discharged from the hospital. These patients 
should remain in quarantine at least 14 days and until a sub-
sequent test turns out negative (two confirmed negative PCR 
swab tests with a 24 h interval) and they are free of fever, 
cough or other symptoms.
Rationale Obviously, if patients show a positive result for 
the PCR test, they should be isolated, the national SARS-
CoV-2 public health protocols should be followed (includ-
ing protocols for exposed staff) and the operation should be 
postponed. There is no exact advice at this point with regard 
to the length of the postponement. Noting that hip and knee 
arthroplasty is elective surgery and that the patient’s safety 
should be optimised, then 3 weeks should be adequate, pro-
vided they do not become symptomatic.
The American College of Surgeons’ advice is to have 
facility-specific SARS-CoV-2 testing policies which would 
then account for how a facility will respond to a SARS-CoV-
2-positive worker, SARS-CoV-2-positive patient (identified 
preoperative or identified post-operative), a ‘person under 
investigation’ (PUI) worker or a PUI patient.
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The CDC protocol is that if an asymptomatic patient 
tests positive for SARS-CoV-2, their operation should be 
rescheduled/cancelled until at least 10 days after their first 
positive SARS-CoV-2 test, assuming they do not subse-
quently develop symptoms. If they have symptoms, their 
operation should be rescheduled or cancelled until it has 
been at least 3 days since the resolution of their fever without 
fever-reducing medications and 3 days since any respiratory 
symptoms (cough, shortness of breath, etc.) have improved 
and they either:
• Test negative from at least two consecutive NP swab 
specimens collected > 24 h apart or
• At least 7  days have passed since symptoms first 
appeared.
5. What kind of back-up plan is needed to guarantee quality 
care and patient safety in this pandemic situation?
Statement The treatment of SARS-CoV-2 patients is placing 
a huge strain on the resources of many hospitals, to the det-
riment of treatment of other health problems. Safety of hip 
and knee arthroplasty patients remains of paramount impor-
tance. Complications of cardiac and respiratory origin are 
the most common problems needing acute care. As elective 
operations begin, every hospital should have ICU capacity 
available to accept and accommodate patients with cardio-
pulmonary or other significant complications. It should be 
assumed that, after the resumption of normal functions at 
hospitals and in society in general, there will still be a risk 
of another outbreak of the disease. In such a situation, hos-
pitals should be prepared to return to a “safe mode” with 
reorganisation of the wards and personnel. Every hospital 
should have in place a plan for emergency distribution of 
the personnel and wards before elective surgery resumes.
Rationale Co-morbidities that are common in surgical pop-
ulations, including hypertension, cardiovascular disease, 
COPD, asthma and malignancies, also place patients at sig-
nificantly higher risk of severe SARS-CoV-2 disease [15].
The advice of the American College of Surgeons is to 
ensure that a post- SARS-CoV-2 outbreak, elective surgery 
surge will not overwhelm local facilities throughout the pre-
operative, intra-operative, post-operative and post-acute care 
phases.
Perioperative phase
1. Is there a need for:
  Modification or reorganisation of hospital wards 
(patient density, bed density, medical and nursing stuff 
density, etc.)?
Statement In most orthopaedic departments, the workforces 
have been adjusted to accommodate fewer cases, due to the 
reduction in trauma cases and cancellation of elective pro-
cedures. As elective operations restart, the standard social 
distancing guidelines should be sufficient. Patient numbers 
in the clinical areas (wards, waiting areas, outpatient clinics) 
should be halved, with the patients spaced at least 2 m apart.
Rationale The International Consensus Group (ICM) and 
the AAHKS Research Committee recommend the follow-
ing (bearing in mind that not every patient may have had a 
SARS-CoV-2 test):
• Patients should be housed in single rooms, if possible. 
When patients are housed in the same room, the beds 
should be spaced at least 2 m (6 ft) apart, and all patients 
should wear a surgical mask
• Commonly touched surfaces should be wiped down and 
cleaned with an effective disinfectant solution (e.g. 70% 
alcohol) at least twice a day
• Any close contact with the patient should be done with 
the use of appropriate PPE, as directed by the institu-
tional policy and in conjunction with national and local 
guidelines
• In the early weeks following the return to elective sur-
gery, each patient should be placed in a single room or 
cubicle where check-in, registration and other administra-
tive tasks are performed.
• Consideration should be given to having a screening 
ward to house patients, especially those who may not 
have been tested for SARS-CoV-2 preoperatively
• Large surgical bays with multiple patients sharing one 
area should be avoided
• Separation of elective and trauma orthopaedic surgery 
(with regard to the general orthopaedic departments)?
Statement SARS-CoV-2 screening practices should ensure 
the health and safety of patients and staff. SARS-CoV-
2-negative elective hip and knee arthroplasty must be sepa-
rated from the SARS-COV-2-positive trauma unit. Since all 
patients undergoing elective procedures are screened before 
administration, and have tested negative for SARS-COV-2, 
they may be reluctant to go into certain settings for fear 
of viral transmission. There should be a physical separa-
tion of SARS-COV-2-positive and SARS-COV-2-negative 
patients and specific wards should be exclusively dedicated 
to treating patients with SARS-CoV-2 to reduce the risk of 
contaminating other patients.
Rationale OrthoEvidence recommends separating, when 
possible, known or suspected SARS-CoV-2 patients from 
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other patients (i.e. designating either SARS-CoV-2 institu-
tions or specific clinical areas, wards and operating theatres).
2. Should relatives/visitors or other supportive personnel 
be allowed onto the orthopaedic wards and operating 
suite?
Statement Until normality returns, the number of visitors 
should be minimised as much as possible to reduce poten-
tial transmission of SARS-CoV-2 among patients, their 
family members and medical staff. This includes sales rep-
resentatives who travel to facilities to undergo, perform 
and support procedures. Limiting interactions between 
individuals and social distancing are part of the main-
stream management against the spread of SARS-CoV-2. 
The number of visitors should be limited to those who are 
essential for a patient’s care. Although it is recognised 
that these rules create considerable anxiety for the patient, 
keeping all patients, relatives and staff safe from SARS-
CoV-2 is the priority.
Rationale All these people, including the medical device 
and implant manufacturer representatives, can transmit the 
SARS-CoV-2 virus not only from person to person at the 
patient’s hospital, but to other health care facilities they may 
visit.
The International Consensus Group (ICM) and the 
AAHKS Research Committee recommend that:
• The use of waiting rooms should be minimised. Social 
distancing in the waiting rooms and other communal 
areas should be exercised. Frequent cleaning is also 
recommended
• Family members and visitors should limit the time they 
spend in the hospital. Some institutions may ban the 
entry of family members and visitors into the hospital
• The surgeon and the surgical team should avoid direct 
contact with family members and should update them 
via telephone or video conferencing
The preoperative setting (clinic, office or non-SARS-
CoV-2-care [NCC] areas) should consider screening 
all patients for symptoms of SARS-CoV-2 before their 
appointment, including temperature checks. All staff and 
others working in the facility (physicians, nurses, house-
keeping, delivery, etc.) should be routinely screen. The 
American College of Surgeons is clear on this topic.
OrthoEvidence recommends limiting or restrict-
ing patient visitors in clinical settings and screening all 
patients and personnel entering clinics and hospitals.
3. Is there a need for extra disinfecting environmental pro-
cedures in between operations?
Statement Standard protocols for cleaning and sterilising 
instruments need to be meticulously applied. Moreover, once 
the patient has departed from the operating room, this should 
be left empty for a specific period of time and all high-touch 
surfaces, including the anaesthetic machine and the anaes-
thetic work area, should be cleaned and disinfected with an 
Environmental Protection Agency (EPA) -approved hospital 
disinfectant. The length of time in between patients depends 
on the number of air exchanges per hour in the room or space 
in question. More detailed guidance is available from the US 
Centers for Disease Control and Prevention (CDC).
Rationale The operating room and surrounding exchange 
areas must be sanitised as soon as possible after each pro-
cedure, with particular attention paid to all objects used in 
caring for patients. Similarly, all areas where SARS-COV-2 
patients have transited must be carefully sanitised, too. All 
personnel must contribute to maintaining a clean environ-
ment, including washing floors and surfaces in general. All 
potentially infected single-use materials should be disposed 
of in IRHW containers. Reusable materials should be decon-
taminated, washed, dried and disinfected or sterilised, based 
on the likelihood of infection. Electromedical equipment 
(i.e. ventilator, radiological equipment) must be cleaned 
with a chloro-derivate solution, rinsed and dried, and then 
disinfected with a chloro-derivate solution in a concentration 
of ≥ 0.1% or 1000 ppm (parts per million) with contact time 
superior to 1 min, or as mandated by local guidelines. Full 
PPE must be worn during the sanitising procedure. Only 
disposable materials should be used for cleaning (i.e. double 
gloves, paper towels). Anything disposable kept inside the 
operating theatre during the procedure must be disposed of 
in IRHW containers, even if it was not used [7].
According to the American College of Surgeons, facil-
ity cleaning policies must be considered in the context of 
SARS-CoV-2. Cleaning (in all areas) needs to be addressed 
along the continuum of care (e.g. clinic, preoperative, ORs, 
workrooms, path-frozen, recovery rooms, wards, ICUs, ven-
tilators, scopes, etc.).
ECDC-Europe recommends regular cleaning followed 
by disinfection, using hospital disinfectants active against 
viruses; cleaning in patient rooms is particularly impor-
tant for frequently touched surfaces. If there is a shortage 
of hospital disinfectants, decontamination may be per-
formed with 0.1% sodium hypochlorite (dilution 1:50 if 
household bleach at an initial concentration of 5% is used) 
after cleaning with a neutral detergent, although no data 
are available on the effectiveness of this approach against 
SARS-CoV-2. Surfaces that may become damaged by 
sodium hypochlorite can be cleaned with a neutral deter-
gent, followed by disinfecting with a 70% ethanol solution.
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4. What roles do ultra-clean operating theatres, orthopaedic 
exhaust suits and ultraviolet light systems play in both 
the wards/beds and the theatre?
Statement Elective orthopaedic theatres and operative 
procedures, including personal protective equipment, 
are designed to reduce the risk of surgical site infection. 
There are no guidelines or protocols published for man-
aging elective hip and knee arthroplasty procedures with 
respect to laminar flow in the presence of SARS-CoV-2. It 
is recommended that surgical helmets not be used as pri-
mary protection against aerosol and airborne disease. The 
surgeon should consider wearing an N95 mask as an added 
precaution when using a surgical helmet in patients con-
sidered to be SARS-CoV-2-negative in the preoperative 
work-up.
Ultraviolet light has no evidence to support its routine use 
and poses a hazard to operating staff.
Rationale
• Health care providers have a duty to protect both patients 
and staff from cross infection
• The risk of transmission of SARS-CoV-2 between staff 
and patient is small when both staff and patient have 
been screened and tested negative. However, transmis-
sion would result in having to quarantine staff members 
if proper PPE has not been used.
• The major transmission risk is aerosol production by 
power tools.
It is preferable that the operating room have a ventilation 
system with a minimum of 20 air changes per hour. Filters 
that are able to remove aerosol particles and droplets can be 
installed, while there is no actual need for negative-pressure 
rooms.
Previous studies performed during the SARS epidemic 
have shown that, commonly used commercially available 
surgical helmets do not filter particles of 0.02–1 μm in diam-
eter to meet the standard for protective respirators. Unlike 
powered air-purifying respirators (PAPRs), which draw 
ambient air through a HEPA filter and blow it over the face, 
surgical helmets filter air through the hood material itself, 
placing the surgeon at risk for viral exposure. Modification 
of the helmet systems using additional 3D printed parts or 
additional filter materials being taped to the helmets have 
been reported but have not been tested widely. The manu-
facturer of one of the most popular helmets cautions against 
these modifications and warns against increased  CO2 con-
centration. N95 masks can be worn under helmets for addi-
tional protection. The International Consensus Group (ICM) 
and the AAHKS Research Committee advises against the 
use of surgical helmets in the setting of elective procedures.
ESSKA guidelines state that aerosol-generating pro-
cedures (AGPs) can be defined as respiratory or surgical. 
Respiratory AGPs, such as intubation, are a high risk for 
transmitting respiratory viral infections, such as COVID-
19. Surgical AGPs, such as the use of high-speed power 
tools, are a high risk for transmitting viruses in body fluids 
and body tissues; SARS-CoV-2 is known to affect all body 
fluids.
Although there is a debate about the necessity of lami-
nar flow for preventing surgical site infection, there is no 
doubt that it is beneficial in reducing the risk of transmis-
sion of fluids between staff working in the operative field 
and patients. Although guidelines for surgery, which cover 
all surgical procedures, do not mention laminar flow and 
exhaust suits as primary protection against aerosol and air-
borne disease, their use (including a mask) for elective hip 
and knee arthroplasty, in which power tools are essential, 
should be recommended [4, 11, 27, 37].
5. What are the guidelines for personal protective equip-
ment (PPE), in terms of availability and instructions 
regarding its use and what to wear in relation to the 
patient’s position in the perioperative chain?
Statement During hip and knee arthroplasty, the use of 
power tools, burrs or electrocautery generates potentially 
infective aerosol. The major aim should be to avoid trans-
mission of SARS-CoV-2 by aerosolisation of blood or other 
body fluids. Hence, adequate personal protective equipment 
should be available and used during surgery. First and fore-
most, all patients undergoing elective surgery should wear a 
mask. Surgeons and the entire surgical team who scrub dur-
ing procedures should ideally wear an exhaust suit, including 
a mask (preferably N95, filtering face piece [FFP2, or P3] 
and a face shield). In the absence of a face shield, protective 
eyewear may be used, but this is a compromise. In addition, 
scrubs should be frequently changed during the surgical day. 
Single-use gowns, single-use gloves and hair and shoe cov-
ers can also, theoretically, reduce the transmission of the 
virus [1, 8, 17, 29, 33].
Rationale For more in-depth outcomes of the systematic 
review and expert opinions on this topic, see Hirschmann 
et al. [16] on PPE use during the SARS-CoV-2 pandemic.
ESSKA Guidelines provide extensive recommendations 
concerning PPE in “Results”: Recommended Personal Pro-
tective Equipment for the Orthopaedic and Trauma Surgeon’.
The American College of Surgeons mentions that PPE 
guidelines should include PPE recommendations for SARS-
CoV-2-positive, PUI and non-SARS-CoV-2 patients for all 
patient care, including high-risk procedures (e.g. intubation, 
chest tubes, tracheostomy).
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• These should be consistent with CDC and Centers for 
Medicare and Medicaid (CMS) recommendations for 
PPEs outside the operating room
• Facilities may consider having all health care workers 
and staff wear appropriate-level PPE, while patients 
wear cloth masks during the ramp-up period and pos-
sibly beyond
OrthoEvidence recommends that all surgeons working 
undergo PPE fit testing and review up-to-date sources for 
training on its appropriate use. Also, contingency plans 
should be developed for supply chain issues.
The current guidelines of the US CDC, along with US 
state, county and local regulations/guidelines, specify the 
following:
• To address asymptomatic and pre-symptomatic transmis-
sion, implement source control for everyone entering a 
health care facility regardless of symptoms:
– Surgical masks are to be used in all clinical areas by 
staff
– Patients may wear either cloth masks or surgical 
masks
– For non-clinical areas, patients and staff may wear 
cloth masks
– Eye protection worn upon entry to the patient room 
or care area
• N95 masks or other FDA/NiOSH approved equivalent 
and eye protection, gowns and gloves should be used for 
procedures that may lead to aerosolisation of viral par-
ticles. N95 with exhaust valves may not provide source 
control and also should not be used in the operating 
room.
The BMJ has an overview of the PPE advice on their web-
site, and the revised guidelines from Public Health England 
recommend that health care workers caring for patients with 
suspected or confirmed SARS-CoV-2 should “have access 
to the PPE that protects them for the appropriate setting and 
context” and that “risk is not uniform and so elements of the 
updated guideline are intended for interpretation and appli-
cation dependent on local assessment of risk”.
Post‑operative phase
1. Since the impact on mind and body during joint arthro-
plasty is significant, do the patients may have lower 
immunity and be more vulnerable to SARS-CoV-2 
infection?
Statement As SARS-CoV-2-positive is an absolute contra-
indication for elective surgery, the standard enhanced recov-
ery protocol for reducing complications is imperative.
Rationale The elderly are at increased risk for adverse 
events. Frailty, more than age, is related to suboptimal out-
comes. In addition to the standard risks, based on the cur-
rently available information and clinical expertise, adults 
65 years and older, people who are overweight and people 
with pre-existing medical conditions (such as asthma, dia-
betes, heart disease) are at higher risk for severe illness and 
death from SARS-CoV-2.
The patient’s immune function is a major determinant 
of the disease’s severity, and people with poor immune 
function, such as older people, are more vulnerable and 
have higher mortality with SARS-CoV-2 infection [21]. 
Surgery may not only cause immediate impairment of 
immune function, but can also induce an early systemic 
inflammatory response. Similar to the impact of infection 
with Middle East Respiratory Syndrome Coronavirus 
(MERS-CoV), the SARS-CoV-2 infected lung can induce 
and increase the amount of macrophage and neutrophil 
infiltration, plus increase levels of pro-inflammatory 
cytokines and chemokines. High levels of circulating 
inflammatory cytokines have been reported to be corre-
lated with the severity of the illness in patients infected 
with SARS-CoV-2.
ESSKA Guidelines emphasise that complete planning 
of the treatment pathway should be made available and 
carefully discussed with the patient prior to any operation. 
Care should be taken to only operate on patients when 
a standardised and adequate post-operative rehabilitation 
can be assured.
The International Consensus Group (ICM) and the 
AAHKS Research Committee recommend that the follow-
ing changes be made in the post-operative care of patients 
during the pandemic:
• The length of hospital stay for patients should be mini-
mised
• Post-operative rounds by the surgeon may be done 
using telemedicine, whenever possible
• Patients should be discharged home and transfer to 
inpatient rehabilitation minimised
• The patient should be instructed on how to perform 
self-directed physical therapy at home
• Post-discharge visits to the office should be minimised, 
with the majority of the follow-up being done by tel-
emedicine
• Office visits should be limited to those who are having 
issues/complications, such as wound healing problems, 
suspected fracture, stiffness and so on
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• Digital health programmes and wearable sensor technolo-
gies that allow monitoring of patients will play a larger 
role in management of patients in the future
• Social distancing should be resumed and at-home visits 
avoided, unless absolutely essential
OrthoEvidence recommends that patients with substantial 
co-morbidities and risk factors should be scheduled after 
healthier patients have been treated and experience has been 
amassed from the establishment of screening, prevention and 
treatment protocols.
2. Should a shelter-in-place post-operative period, home 
care, community nurses or informal care be organised?
Statement Ideally, patients should be discharged home with 
the standard SARS-CoV-2 precautions being taken and only 
transferred to a nursing home in cases where that is not pos-
sible, since higher rates of SARS-CoV-2 may exist in those 
facilities.
Rationale The communal nature of nursing homes and long-
term care facilities and the characteristics of the population 
served (generally older adults, often with underlying medi-
cal conditions) put those living in nursing homes at higher 
risk of infection and severe illness from SARS-CoV-2. Until 
normality returns, unnecessary human contact should be 
avoided as much as possible to reduce the potential trans-
mission of SARS-CoV-2 among patients and their family 
members. All these people, including family members and 
nurses, can transmit the SARS-CoV-2 virus from one person 
to another and from one location to another.
The International Consensus Group (ICM) and the 
AAHKS Research Committee recommend using the gen-
eral principles of social distancing and minimising contact 
between individuals. Although no specific studies have been 
completed relating to the post-operative care of orthopaedic 
patients, logically one would expect that minimising hospital 
stays and minimising transfer to rehabilitation facilities or 
other health care settings are likely to reduce the risk for 
transmission of the disease.
ESSKA Guidelines highlight that care should be taken 
to only operate on patients when a standardised protocol for 
adequate post-operative rehabilitation is in place.
The American College of Surgeons’ advice is to evalu-
ate and discuss the patient’s potential need for a post-acute 
care facility (rehabilitation medicine, skilled nursing facility, 
other) before the operation, taking into account the known 
SARS-CoV-2 outbreaks in the relevant post-acute care 
facilities.
3. Avoid face-to-face contact for the orthopaedic follow-up 
and physical therapy guidance
• Consider telemedicine
Statement Web-based tools and telemedicine are preferred 
during this SARS-CoV-2 pandemic and may become the 
standard in the post-pandemic era.
Rationale The use of internet video conferencing in health 
care settings (telemedicine) is widespread [38], reflecting the 
normalisation of this mode of communication in society and 
current health care policy. During this SARS-CoV-2 pan-
demic, especially, telemedicine is a great tool for minimising 
physical contact and avoiding SARS-CoV-2 transmission in 
accordance with general social distancing principles. Tel-
emedicine can be rapidly integrated and easily transitioned 
to. Similar outcomes to inpatient visits have been reported 
in rural areas, with good to excellent results in 95% of cases 
[41]. The combination of web-based platforms and the 
widespread use of mobile devices allows for reducing post-
discharge visits, with early detection and management of 
post-operative adverse events, including problems related to 
medication, wound healing and activity. Home exercises for 
physical therapy can be provided via web-based platforms. 
Among the limitations of telemedicine is that no physical 
examinations are possible; no critical assessment of associ-
ated conditions and potentially dangerous side effects can 
be evaluated [39]. This might compromise patient care. 
All stakeholders using telemedicine must be aware that 
cybersecurity is also a fundamental issue. The latest reports 
therefore recommend using secure patient portals instead 
of popular public services, which can compromise sensi-
tive patient data. Secure patient portals are less vulnerable 
to cyber-attacks, and patient data can be stored on a secure 
server. Should popular public services manage to improve 
their data security guidelines, they might become an option 
again [41]. Health care payers’, regulatory and legal restric-
tions and requirements for telemedicine in each country will 
have to be considered. Each health care facility will have 
established procedures for this. In the EU and UK, the use 
of personal devices risks both heavy fines if the law is not 
meticulously followed and employment problems for people 
working at a national health care facility.
OrthoEvidence recommends online/telerehabilitation 
platforms to facilitate remote access while distancing meas-
ures are in place.
The International Consensus Group (ICM) and the 
AAHKS Research Committee recommend that the follow-
ing changes be made in the post-operative care of patients 
during the pandemic:
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• Post-discharge visits to the office should be minimised, 
with the majority of the follow-up being done by tel-
emedicine.
• Digital health programmes and wearable sensor tech-
nologies that allow monitoring of patients can play a 
larger role in the management of patients in the future.
The AIOT Joint Statement on COVID-19 Best Practices 
recommends:
• Minimising imaging requirements
• Avoiding taking images that are unlikely to change 
patients’ management
• Preventing unnecessary follow-up appointments
Promoting telehealth modalities to increase access for 
diagnostic and rehabilitation purposes.
• Consider a new approach in wound closure technique 
in the setting of the SARS-CoV-2 pandemic
Statement Post-operative in-office visits should be mini-
mised, and digital health programmes allowing health care 
providers to closely monitor patients remotely should be 
supported. Self-administered wound management should 
become the standard of care for patients in the post-pan-
demic era.
Rationale The goal of this approach is to avoid a follow-up 
visit at 2 weeks from the original operation. Modern, fast-
track wound closure techniques need to be applied in the 
wake of SARS-CoV-2. Capsular closure has traditionally 
been performed using interrupted knotted sutures; in recent 
years, the number 1 knotless barbed suture has been intro-
duced, allowing for a running technique aimed at reducing 
closure time, while still providing excellent results. The sub-
cutaneous fat layer, when substantial, should be closed using 
synthetic, absorbable, braided sutures or bidirectional barbed 
sutures. Barbed sutures also demonstrate significantly less 
bacterial adherence than conventional braided sutures. Skin 
closure should be performed using 2-octyl cyanoacrylate 
(glue) and polyester mesh with or without monocryl running 
suture. This technique allows for patient self-management of 
the wound and offers superior cosmetic outcomes to staples. 
The use of video-based digital technologies will allow the 
health care provider to monitor the wound healing process 
remotely [20, 23, 36].
4. What is the advice for patients who develop SARS-
CoV-2 symptoms?
Statement In the event a patient develops SARS-CoV-2 
symptoms or comes into contact with a SARS-CoV-2-posi-
tive person, they should seek health care advice. The patient 
should use the system in place in their country to seek the 
relevant advice. This may be through their primary care 
physician or an online or telephone advice service. Their 
orthopaedic surgeon and hospital should also be notified.
Rationale It is important to recognise the danger signs. If 
early symptoms of SARS-CoV-2 are missed, patients, par-
ticularly the elderly, may deteriorate rapidly before getting 
needed care. If the patient has a fever or acute respiratory 
illness, they should immediately seek health advice.
OrthoEvidence recommends online or telerehabilitation 
platforms; this will facilitate early detection of SARS-CoV-2 
symptoms by the surgeon or hospital.
The WHO advice is:
• If you have minor symptoms, such as a slight cough or 
a mild fever, there is generally no need to seek medical 
care. Stay at home, self-isolate and monitor your symp-
toms. Follow national guidance on self-isolation
• However, if you live in an area with malaria or dengue 
fever, it is important that you do not ignore symptoms 
of fever. Seek medical help. When you attend the health 
facility, wear a mask if possible, keep at least 1-m dis-
tance from other people and do not touch surfaces with 
your hands. If it is a child who is sick, help the child stick 
to this advice
• Seek immediate medical care if you have difficulty 
breathing or pain or pressure in the chest. If possible, 
call your health care provider in advance, so they can 
direct you to the right health care facility.
The International Consensus Group (ICM) and the 
AAHKS Research Committee recommend that if a patient is 
positive for SARS-CoV-2, as determined by an RT-PCR test 
after a surgical procedure, all health care workers who came 
into contact with the patient without using PPE, and are not 
known to have antibodies against SARS-CoV-2, should be 
tested and quarantined until their test results become avail-
able. Decisions regarding the need to quarantine staff should 
be made in tandem with the hospital infection control team 
and employee health department. The patient should also 
be isolated and any contact with the patient should be with 
the use of full PPE.
The American College of Surgeons mentions guidelines 
and considerations for post-operative SARS-CoV-2 test-
ing of symptomatic patients or patients under investigation 
(PUI). Atelectasis, fevers, et cetera, are not uncommon in the 
post-operative course. Establishing operational guidelines 
for SARS-CoV-2 testing in these patients and concurrent 
testing results should be considered.
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5. Are special adjustments needed for post-op SARS-
CoV-2 prophylaxis?
Statement Since SARS-CoV-2-positive is an abso-
lute contra-indication for elective surgery, the standard 
enhanced recovery protocol and SARS-CoV-2 preven-
tive measures are imperative. Time allowing, all surgi-
cal patients should apply social distancing principles for 
the first 2 weeks after the operation and self-quarantine 
in their home.
Rationale To date, there is no known SARS-CoV-2 prophy-
laxis advice; the standard enhanced recovery protocols and 
SARS-CoV-2 preventive actions should prevail.
To prevent infection and slow transmission of SARS-
CoV-2, do the following:
• Wash your hands regularly with soap and water or clean 
them with alcohol-based hand rub
• Maintain at least a 1.5-m distance between you and 
people coughing or sneezing
• Avoid touching your face
• Cover your mouth and nose when coughing or sneezing
• Stay home if you feel unwell
• Refrain from smoking and other activities that weaken 
the lungs
• Practice physical distancing by avoiding unnecessary 
travel and staying away from large groups of people.
The International Consensus Group (ICM) and the 
AAHKS Research Committee do not recommend that anti-
biotic or venous thromboembolism (VTE) prophylaxis be 
altered in patients undergoing elective surgery during the 
SARS-CoV-2 pandemic.
Discussion
The recommendations have been based on the available 
evidence and have been validated by a survey of the EHS 
and EKA membership [19]. They have been set out to fol-
low the sequence of events that take a patient to an oper-
ating theatre for an elective primary hip or knee arthro-
plasty, and then into the recovery period. Implementation 
of the recommendations will require a multidisciplinary 
approach that includes hospital management, and includes 
the production of guidelines, staff training, patient infor-
mation material, and finance. However the goal is to 
undertake operations effectively and safely for the patients 
and the staff. At the same time planning needs to begin on 
how to manage a new phase of SARS-CoV-2.
Conclusions
The recommendations can be summarised as:
1. National guidance for the management of the SARS-
CoV-2 pandemic should be adhered to.
2. National and local guidance for the pathway for elective 
arthroplasty should be followed.
In addition:
 (i) Patient information materials should now include 
information on what the patient should do if they 
develop SARS-CoV-2 symptoms or become SARS-
CoV-2 positive whilst on the elective arthroplasty 
pathway.
 (ii) Patients should only be accompanied by their pri-
mary caregiver during their elective hip or knee 
arthroplasty pathway.
 (iii) The appropriate facilities, workforce, testing and sup-
plies for all the equipment needed must be in place.
 (iv) Agreed protocols should be in place for select-
ing suitable patients, taking into consideration the 
resources available to cater to their needs on an indi-
vidual basis.
 (v) A robust testing regime for SARS-CoV-2 for both 
patients and staff should be in place and incorpo-
rated into the protocols for the patient journey. Being 
SARS-CoV-2-positive is an absolute contra-indica-
tion for primary elective hip and knee arthroplasty.
 (vi) Enhanced recovery protocols are encouraged, with a 
further reduction in the inpatient stay implemented.
 (vii) To reduce the risk of aerosolisation to staff, the use 
of spinal anaesthetic techniques is encouraged and 
should be included in the patient information mate-
rial. An agreed policy must be in place on how to 
manage patients who can only undergo a general 
anaesthetic, which may include this being a contra-
indication for surgery.
 (viii) Theatre staff should use personal protective equip-
ment (PPE) in line with national and local policies. 
Laminar flow theatres are encouraged, and, if avail-
able, exhaust suits with a mask should be used for the 
operating team.
 (ix) Primary elective hip and knee arthroplasty patients 
should be physically isolated from patients admitted 
with trauma or for other emergencies, including the 
sick elderly.
 (x) Ideally, patients should be discharged directly back 
to their normal residence. Patients should be advised 
to maintain social distancing for 2 weeks following 
discharge.
2745Knee Surgery, Sports Traumatology, Arthroscopy (2020) 28:2730–2746 
1 3
 (xi) Post-operative rehabilitation should be implemented 
during the inpatient stay, with remote follow-up as 
the norm after discharge.
 (xii) Follow-up visits should be minimised and remote 
follow-up instituted with the relevant approvals with 
respect to Patient Confidentiality and Data Protection 
in place.
Funding No funding has been provided for this study.
Compliance with ethical standards 
Conflict of interest NC has provided consultancy services to Stryker 
Netherlands (Amsterdam), Zimmer-Biomet (Warsaw Indiana) and 
BodyCad (Naples USA). No other conflicts of interest have been re-
corded.
Ethical approval This article does not contain any studies with human 
participants or animals performed by any of the authors.
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long 
as you give appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons licence, and indicate if changes 
were made. The images or other third party material in this article are 
included in the article’s Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not included in 
the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will 
need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
References
 1. Aggarwal N (2020) Importance of social distancing: mod-
eling the spread of 2019-nCoV using susceptible-infected-
quarantined-recovered-t model. MedRxiv. https ://doi.
org/10.1101/2020.04.17.20069 245
 2. Al-Muharraqi MA (2020) Testing recommendation for COVID-19 
(SARS-CoV-2) in patients planned for surgery—continuing the 
service and ’suppressing’ the pandemic [published online ahead 
of print, 2020 Apr 13]. Br J Oral Maxillofac Surg. https ://doi.
org/10.1016/j.bjoms .2020.04.014
 3. Aminian A, Kermansaravi M, Azizi S, Peyman A, Safamanesh S, 
Mousavimaleki A et al (2020) Bariatric surgical practice during 
the initial phase of COVID-10 outbreak. Obes Surg 30:3624–3627
 4. Anon (2020) Covid-19: Good Practice for Surgeons and Surgical 
Teams. Royal College of Surgeons of England 2020. https ://www.
rcsen g.ac.uk/stand ards-and-resea rch/gsp/. Accessed 7 May 2020
 5. Brown TS, Bdard NA, Rojas EO, Prieto H, Parvizi J (2020) The 
effect of the COVID-19 pandemic on electively scheduled hip 
and knee arthroplasty patients in the United States. J Arthroplasty 
35(7S):S49–S55. https ://doi.org/10.1016/j.arth.2020.04.052
 6. Centers for Medicare & Medicaid Services (CMS) Recom-
mendations Re-opening Facilities to Provide Non-emergent 
Non-COVID-19 Healthcare: Phase. https ://www.cms.gov/files /
docum ent/covid -flexi bilit y-reope n-essen tial-non-covid -servi ces.
pdf. Accessed 5 May 2020
 7. Coccolini F, Perrone G, Chiarugi M, Di Marzo F, Ansaloni 
L, Scandroglio I et al (2020) Surgery in COVID-19 patients: 
operational directives. World J Emerg Surg 15:25. https ://doi.
org/10.1186/s1301 7-020-00307 -2
 8. Coimbra R, Edwards S, Kurihara H, Bass GA, Balogh ZJ, Tilsed J 
et al (2020) European Society of Trauma and Emergency Surgery 
(ESTES) recommendations for trauma and emergency surgery 
preparation during times of COVID-19 infection. Eur J Trauma 
Emerg Surg. https ://doi.org/10.1007/s0006 8-020-01364 -7
 9. D’Apolito R, Faraldi M, Ottaiano I, Zagra L (2020) Disruption 
of arthroplasty practice in an orthopaedic Center in Northern 
Italy during COVID-19 pandemic. J Arthroplasty. https ://doi.
org/10.1016/j.arth.2020.04.057
 10. ESSKA (2020) Which patients should you begin with for elec-
tive orthopaedic surgery? https ://cdn.ymaws .com/www.esska 
.org/resou rce/resmg r/covid -19/Surgi cal_prior ities .pdf. Accessed 
1 May 2020
 11. Evans RP (2011) Current concepts for clean air and total joint 
arthroplasty: laminar airflow and ultraviolet radiation. Clin Orthop 
Relat Res 469:945–952
 12. Fineberg HV (2020) Ten weeks to crush the curve. N Engl J Med 
382(17):e37. https ://doi.org/10.1056/NEJMe 20072 63
 13. Fujihara N, Lark ME, Fujihara Y, Chung KC (2017) The effect 
of economic downturn on the volume of surgical procedures: a 
systematic review. Int J Surg 44:56–63
 14. Ghomrawi HMK, Mushlin AI, Kang R, Banerjee S, Singh 
JA, Sharma L et al (2020) Examining timeliness of total knee 
arthroplasty among patients with knee osteoarthritis in the US: 
results from the OAI and MOST longitudinal cohorts. J Bone 
Jt Surg Am 102(6):468–476
 15. Guan W-J, Liang W-H, Zhao Y, Liand H-R, Chen Z-S, Li 
Y-M et al (2020) Comorbidity and its impact on 1590 patients 
with Covid-19 in China: a Nationwide analysis. Eur Respir J 
55(5):2000547. https ://doi.org/10.1183/13993 003.00547 -2020
 16. Hirschmann MT, Hart A, Henckel J, Sadoghi P, Seil R, Mou-
ton C (2020) COVID-19 coronavirus: recommended personal 
protective equipment for the orthopaedic and trauma surgeon. 
Knee Surg Sports Traumatol Arthrosc. https ://doi.org/10.1007/
s0016 7-020-06022 -4
 17. Klompas M, Morris CA, Sinclair J, Pearson M, Shenoy ES 
(2020) Universal masking in Hospitals in the Covid-19 era. N 
Engl J Med 382:e63. https ://doi.org/10.1056/nejmp 20063 72
 18. Koenig L, Zhang Q, Austin MS, Demiralp B, Fehring TK, Feng 
C et al (2016) Estimating the societal benefits of THA after 
accounting for work status and productivity: a Markov model 
approach. Clin Orthop Relat Res 474(12):2645–2654
 19. Kort NP, Gómez Barrena E, Bédard M, Donell S, Epinette 
J-A, Gomberg B et al (2020) A survey of recommendations 
for resuming elective hip and knee arthroplasty after the first 
phase of the SARS-CoV-2 pandemic: The European Hip Society 
and European Knee Associates. Knee Surg Sports Traumatol 
Arthrosc. https ://doi.org/10.1007/s0016 7-020-06212 -0
 20. Krebs VE, Elmallah RK, Khlopas A, Chughtai M, Bonutti P, 
Roche M et al (2018) Wound closure techniques for total knee 
arthroplasty: an evidence-based review of the literature. J Arthro-
plasty 33:633–638
 21. Lei S, Jiang F, Su W, Chen C, Chen J, Mei W et al (2020) Clini-
cal characteristics and outcomes of patients undergoing surgeries 
during the incubation period of COVID-19 infection. E Clin Med 
21:100331. https ://doi.org/10.1016/j.eclin m.2020.10033 1
 22. Li Y, Fu J-B, Li K-F, Liu J-N, Wang H-L, Liu L-J et al (2020) 
Transmission of COVID-19 in the terminal stages of the incuba-
tion period: a familial cluster. Int J Infect Dis 96:452–453
2746 Knee Surgery, Sports Traumatology, Arthroscopy (2020) 28:2730–2746
1 3
 23. Lie SA, Wong SW, Wong LT, Wong TGL, Chong SY (2020) Prac-
tical considerations for performing regional anesthesia: lessons 
learned from the COVID-19 pandemic. Can J Anesth 67:885–892. 
https ://doi.org/10.1007/s1263 0-020-01637 -0
 24. Meneghini RM (2020) Resource reallocation during the COVID-
19 pandemic in a suburban hospital system: implications for out-
patient hip and knee arthroplasty. J Arthroplasty 35(7):S15–S18
 25. Mouton C, Hirschmann M, Ollivier M, Seil R, Menetrey J (2020) 
COVID-19—ESSKA Guidelines and Recommendations for 
Resuming Elective Surgery. https ://cdn.ymaws .com/www.esska 
.org/resou rce/resmg r/covid -19/COVID -guide lines -Q&A.pdf. 
Accessed 1 May 2020
 26. Mujica-Mota RE, Watson LK, Tarricone R, Jager M (2017) Cost-
effectiveness of timely versus delayed primary total hip arthro-
plasty in Germany: a social health insurance perspective. Orthop 
Rev 9(3):76–87
 27. National Institute for Health and Care Excellence (2020) Joint 
arthroplasty (primary): hip, knee and shoulder. NICE guideline 
[NG157] www.nice.org.uk/guida nce/ng157 . Accessed 7 May 
2020
 28. Park SY, Kim YM, Yi S, Lee S, Na BJ, Kim CB et al (2020) Coro-
navirus disease outbreak in call center, South Korea. Emerg Infect 
Dis 26(8):1666–1670. https ://doi.org/10.3201/eid26 08.20127 4
 29. Parvizi J, Gherke T, Krueger JA, Chisari E, Citak M (2021) 
Resuming elective surgery during the COVID-19 pandemic. J 
Bone Jt Surg Am. https ://doi.org/10.2106/JBJS.20.00844 
 30. Patel R, Babady E, Theel ES, Storch GA, Pinsky BA, St George 
K et al (2020) Report from the American Society for Microbiol-
ogy COVID-19 International Summit, 23 March 2020: value of 
diagnostic testing for SARS–CoV-2/COVID-19. mBio 11:2. https 
://doi.org/10.1128/mBio.00722 -20
 31. Pollock M, Somerville L, Firth A, Lanting B (2016) Outpatient 
total hip arthroplasty, total knee arthroplasty, and unicompartmen-
tal knee arthroplasty: a systematic review of the literature. JBJS 
Rev 4:01874474–201612000
 32. Prachand VN, Milner R, Angelos P, Posner MC et al (2020) Medi-
cally necessary, time-sensitive procedures: scoring system to ethi-
cally and efficiently manage resource scarcity and provider risk 
during the COVID-19 pandemic. J Am Coll Surg 231:281–288
 33. Rodrigues-Pinto R, Sousa R, Oliveira A (2020) Preparing to per-
form trauma and orthopaedic surgery on patients with COVID-19. 
J Bone Jt Surg Am. https ://doi.org/10.2106/jbjs.20.00454 
 34. Rossi MD, Eberle T, Roche M, Waggoner M, Blake R, Burwell 
B, Baxter A et al (2009) Delaying knee arthroplasty and implica-
tions on early postoperative outcomes: a pilot study. Orthopedics 
32(12):885
 35. Ruiz D Jr, Koenig L, Dall TM, Gallo P, Narzikul A, Parvizi 
J et al (2013) The direct and indirect costs to society of treat-
ment for end-stage knee osteoarthritis. J Bone Jt Surg Am 
95(16):1473–1480
 36. Sanger PC, Simianu VV, Gaskill CE, Armstrong CAL, Hart-
zler AL, Lordon RJ et al (2017) Diagnosing surgical site infec-
tion using wound photography: a scenario-based study. J Am 
Coll Surg 224(1):8–15.e1. https ://doi.org/10.1016/j.jamco llsur 
g.2016.10.027
 37. Smit S (2010) Guidelines for surgery in the HIV patient. CME 
28:356–357
 38. Smith WR, Atala AJ, Terlecki RP, Kelly EE, Matthews CA 
(2020) Implementation guide for rapid integration of an outpa-
tient telemedicine program during the COVID-19 pandemic. Acad 
Oncol Nurse Patient Navig. https ://doi.org/10.1016/j.jamco llsur 
g.2020.04.030
 39. Sundaram K, Piuzzi NS, Patterson BM, Stearns KL, Krebs VE, 
Mont MA (2020) Skin closure with 2-octyl cyanoacrylate and pol-
yester mesh after primary total knee arthroplasty offers superior 
cosmetic outcomes and patient satisfaction compared to staples: a 
prospective trial. Eur J Orthop Surg Traumatol 30:447–453. https 
://doi.org/10.1007/s0059 0-019-02591 -4
 40. Soffin EM, YaDeau JT (2016) Enhanced recovery after surgery 
for primary hip and knee arthroplasty: a review of the evidence. 
Br J Anaesth 117(suppl 3):iii62–iii72
 41. Tanaka MJ, Oh LS, Martin SD, Berkson EM (2020) Telemedi-
cine in the era of COVID-19: the virtual orthopaedic examina-
tion. J Bone Jt Surg Am 102(12):e57. https ://doi.org/10.2106/
JBJS.20.00609 
 42. Wainwright TW, Gill M, McDonald DA, Middleton RG, Reed 
M, Sahota O et al (2020) Consensus statement for perioperative 
care in total hip arthroplasty and total knee arthroplasty surgery: 
Enhanced Recovery After Surgery (ERAS(®))Society recommen-
dations. Acta Orthop 91(1):3–19
 43. White House (2020) Guideline Opening Up America Again. https 
://www.white house .gov/openi ngame rica/#crite ria. Accessed 15 
May 2020
 44. Zhu S, Qian W, Jiang C, Ye C, Chen X (2017) Enhanced recovery 
after surgery for hip and knee arthroplasty: a systematic review 
and meta-analysis. Postgrad Med J 93:736–742
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
